|
Welcome,
Guest
|
TOPIC:
Hep C butterfly posters translated: Mandarin, Arabic and more 2 years 8 months ago #28502
With many thanks to Dr Bronwyn Carlisle and the international PhD students in Biochemistry at Otago University, I have here translated versions of our "Imagine" posters. Originals in English here www.hepc-action.nz/resources/#the-butterfly please feel free to do other languages for us- just the text. I'd quite like some of the Old and Tired one too! Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
|
|
|
Please Log in or Create an account to join the conversation. |
Hep C butterfly posters translated: Mandarin, Arabic and more 2 years 8 months ago #28505
|
Amazing work Hazel and Dr James and all those involved in this effort, you guys rock
 |
|
|
Please Log in or Create an account to join the conversation. |
Hep C butterfly posters translated: Mandarin, Arabic and more 2 years 7 months ago #28515
|
Thanks for your help with it Mar! Here is French,
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
|
|
|
Please Log in or Create an account to join the conversation. |
Hep C butterfly posters translated: Mandarin, Arabic and more 2 years 7 months ago #28516
|
You're welcome Hazel, you're doing an amazing job
|
|
|
Please Log in or Create an account to join the conversation. |
Hep C butterfly posters translated: Mandarin, Arabic and more 2 years 7 months ago #28519
|
And Italian
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
|
|
|
Please Log in or Create an account to join the conversation. |
Time to create page: 0.061 seconds
